Scapular Mobilization With Arm Movement in Patients With Adhesive Capsulitis.

Effect of Scapular Mobilization With Arm Movement on Shoulder Pain and Range of Motion and Disability in Older Adults With Adhesive Capsulitis.

50 patients with shoulder adhesive capsulitis were admitted. the patients will receive scapular mobilization (downward or upward mobilization) associated with arm movements. The percentage of improvement in shoulder ROM of flexion, abduction, and external rotation; and decrease in shoulder pain and disability index (SPADI).

Study Overview

• Status: Not yet recruiting
• Conditions: Shoulder Adhesive Capsulitis
• Intervention / Treatment: Other: Scapular mobilization with movement

• Study Type: Interventional
• Enrollment (Estimated): 50
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ayman AM Mohamed, PhD, MPT, DPT; Phone Number: +201141776364; Email: dr_ayman_pt@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• The existence of unilateral adhesive capsulitis (stage II) with incapability of the participant to raise the arm more than 100 degrees in the plane of the scapula

Exclusion Criteria:

• The presence of any shoulder problem contraindicated for performing exercises to the shoulder joint, such as active inflammatory disease, cancer, active infection, recent subluxations or dislocations, fractures, and surgeries near the shoulder region.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Quadruple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control
Experimental: Scapular mobilization with movement; The treatment consisted of scapular mobilization with arm movement in all directions for 15 min/session for 3 sessions/week for 4 weeks. Scapular mobilization included scapular upward glide and downward glid. Scapular upward glide was performed with shoulder adduction and extension, while scapular downward glide was performed with shoulder abduction and flexion.	Other: Scapular mobilization with movement; The treatment consisted of scapular mobilization with arm movement in all directions for 15 min/session for 3 sessions/week for 4 weeks. Scapular mobilization included scapular upward glide and downward glid. Scapular upward glide was performed with shoulder adduction and extension, while scapular downward glide was performed with shoulder abduction and flexion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Shoulder Pain and Disability Index (SPADI)	The patient was asked to refer to the degree of their shoulder problems in the previous week by choosing a number on a scale from 0 (no pain or disability) to 10 (extreme pain and disability) for each question 13. The chosen number from each subscale was summed up and transformed into an out-of-100 score. The mean two scales were assigned a sum score out of 100. The higher the end score, the more shoulder pain, or disability.	3 months
Shoulder range of motion of flexion, abduction, and external rotation	For evaluating shoulder flexion and abduction, the goniometer was positioned on the distal arm. The patient sat in a vertical position on an elevated-backed chair. To restrain trunk unwanted motion, a belt was put around the patient's waist and chair. The patient was directed to lift the tested arm voluntarily with his palm facing the floor. For evaluating shoulder external rotation, the goniometer was positioned on the proximal forearm next to the wrist joint. The patient was asked to lie supine with flexed hips and knees 45 degrees. The tested arm was placed on the plinth with 90 degrees in shoulder abduction, 90 degrees in elbow flexed, and 0 degrees in wrist joint11. The patient was asked to turn the forearm up to externally rotate the arm.	3 months
Scapular dyskinesis	this test was conducted with grasping dumbbells following the bodyweight, 1.4 kg (3 lb) for patients with a weight of lower than 68.1 kg (150 lb), and 2.3 kg (5 lb) for patients with a weight of 68.1 kg or higher. If any patient was unable to carry these predetermined weights, the weight was decreased by 0.5 kg29. Then, the patient was instructed to instantaneously raise his arms overhead with thumbs-up as much as possible at a 3-second count and then lower the arms back to the same starting position at a 3-second count. This study used a caliper to develop an objective method to measure improved scapular dyskinesis. The height difference between the 2 scapulae was measured with a caliper to the nearest millimeters at the end of the available shoulder ROM. The height difference between the 2 scapulae was defined as the difference between the vertical positions of the 2 inferior angles of the 2 scapulae30. A distance of more than 75 mm between the 2 scapulae was c	3 months
Electromyography	Electromyographical analysis of Upper and Lower trapezius and Serratus anterior	3 months

Collaborators and Investigators

• Sponsor: Beni-Suef University

Study record dates

Study Major Dates

• Study Start (Estimated): October 15, 2024
• Primary Completion (Estimated): January 31, 2025
• Study Completion (Estimated): February 15, 2025

Study Registration Dates

• First Submitted: September 26, 2024
• First Submitted That Met QC Criteria: September 26, 2024
• First Posted (Actual): October 1, 2024

Study Record Updates

• Last Update Posted (Actual): October 1, 2024
• Last Update Submitted That Met QC Criteria: September 30, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Keywords: scapular mobilization; arm movement; pain; range of motion; disability; older adults; adhesive capsulitis
• Additional Relevant MeSH Terms: Joint Diseases; Musculoskeletal Diseases; Bursitis
• Other Study ID Numbers: BNS

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No